Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: A FISH mapping study of CML patients and cell lines

Molecular Cytogenetics

Volumn 3, Issue 1, 2010, Pages

  Virgili, Anna ^a   Nacheva, Elisabeth P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; CELL LINE; CELL POPULATION; CHROMOSOME 22; CHROMOSOME 9Q; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC GAIN; HUMAN; HUMAN CELL; ISOCHROMOSOME; METAPHASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 77956479163     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-3-15     Document Type: Article

References (17)

1. Chronic myeloid leukaemia as a model of disease evolution in human cancer. JV Melo DJ Barnes, Nature reviews 2007 7 441 453 10.1038/nrc2147 17522713
2. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. ME Gorre M Mohammed K Ellwood N Hsu R Paquette PN Rao CL Sawyers, Science (New York, NY) 2001 293 876 880
3. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. A Hochhaus S Kreil AS Corbin P La Rosee MC Muller T Lahaye B Hanfstein C Schoch NC Cross U Berger H Gschaidmeier BJ Druker R Hehlmann, Leukemia 2002 16 2190 2196 10.1038/sj.leu.2402741 12399961
4. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. A Quintas-Cardama J Cortes, Blood 2009 113 1619 1630 10.1182/blood-2008-03-144790 18827185
5. Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients. CM Szych JL Liesveld MA Iqbal L Li S Siebert C Asmus J O'Malley A Lee N Wang, Cancer genetics and cytogenetics 2007 174 132 137 10.1016/j.cancergencyto.2006.12.001 17452255
6. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration. LJ Campbell C Patsouris KC Rayeroux K Somana EH Januszewicz J Szer, Cancer genetics and cytogenetics 2002 139 30 33 10.1016/S0165-4608(02)00615-5 12547154
7. Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia. PM Gargallo MT Cuello PN Aranguren IB Larripa, Cancer genetics and cytogenetics 2003 143 140 144 10.1016/S0165-4608(02)00854-3 12781448
8. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. CL Phan PJ Megat Baharuddin LP Chin Z Zakaria S Yegappan J Sathar SM Tan V Purushothaman KM Chang, Cancer genetics and cytogenetics 2008 180 60 64 10.1016/j.cancergencyto.2007.09.014 18068536
9. Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression. D Brazma C Grace J Howard JV Melo T Holyoke JF Apperley EP Nacheva, Genes, chromosomes & cancer 2007 46 1039 1050
10. Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization. SM Gribble I Roberts C Grace KM Andrews AR Green EP Nacheva, Cancer genetics and cytogenetics 2000 118 1 8 10.1016/S0165-4608(99)00169-7 10731582
11. Isodicentric Philadelphia chromosome in accelerated phase of chronic myeloid leukemia. F Pernice G Squadrito A Saitta G Mazza C Musolino, Cancer genetics and cytogenetics 1993 66 113 116 10.1016/0165-4608(93)90238-H 8500097
12. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia. S Metzke-Heidemann L Harder S Gesk R Schoch S Jenisch W Grote R Siebert B Schlegelberger, Genes, chromosomes & cancer 2001 31 10 14
13. FISH mapping of Philadelphia negative BCR/ABL1 positive CML. A Virgili D Brazma AG Reid J Howard-Reeves M Valganon A Chanalaris VA De Melo D Marin JF Apperley C Grace EP Nacheva, Molecular Cytogenetics 2008 1 14 10.1186/1755-8166-1-14 18638369
14. Multiple copies of a rare rearrangement of Philadelphia chromosome in a chronic myeloid leukemia patient: a case report. C Li Ming Chua YY Tan SP Chua HB Ma E Koay M Li Min Poon TC Liu L Gole, Cancer genetics and cytogenetics 2010 199 66 68 10.1016/j.cancergencyto.2010.01.012 20417874
15. Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571. A Sirulink RT Silver V Najfeld, Leukemia 2001 15 1795 1797 11681425
16. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib. D Gadzicki N von Neuhoff D Steinemann M Just G Busche H Kreipe L Wilkens B Schlegelberger, Cancer genetics and cytogenetics 2005 159 164 167 10.1016/j.cancergencyto.2004.09.021 15899391
17. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib. F Morel MJ Bris A Herry GL Calvez V Marion JF Abgrall C Berthou MD Braekeleer, European journal of haematology 2003 70 235 239 10.1034/j.1600-0609.2003.00046.x 12656747